The present invention relates to novel benzimidazole derivatives, pharmaceutical compositions containing these compounds, and methods of treatment using the same. The compounds herein are useful for the treatment of central nervous system diseases and disorders, which are particularly responsive to the regulation of the GABA A receptor complex to combat anxiety and related diseases.